Michael J. Blankinship, Ph.D. - Publications

Affiliations: 
2005 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
muscle gene therapy, DMD

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, Miller AD, Chamberlain JS. Erratum to "Efficient Transduction of Skeletal Muscle Using Vectors Based on Adeno-associated Virus Serotype 6". Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1482. PMID 28160909 DOI: 10.1038/Mt.2009.135  0.699
2009 Gregorevic P, Schultz BR, Allen JM, Halldorson JB, Blankinship MJ, Meznarich NA, Kuhr CS, Doremus C, Finn E, Liggitt D, Chamberlain JS. Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1427-33. PMID 19471246 DOI: 10.1038/Mt.2009.116  0.736
2008 Davis J, Westfall MV, Townsend D, Blankinship M, Herron TJ, Guerrero-Serna G, Wang W, Devaney E, Metzger JM. Designing heart performance by gene transfer. Physiological Reviews. 88: 1567-651. PMID 18923190 DOI: 10.1152/Physrev.00039.2007  0.54
2008 Gregorevic P, Blankinship MJ, Allen JM, Chamberlain JS. Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 657-64. PMID 18334986 DOI: 10.1038/Mt.2008.28  0.704
2008 Gregorevic P, Meznarich NA, Blankinship MJ, Crawford RW, Chamberlain JS. Fluorophore-labeled myosin-specific antibodies simplify muscle-fiber phenotyping. Muscle & Nerve. 37: 104-6. PMID 17691104 DOI: 10.1002/Mus.20877  0.638
2007 Townsend D, Blankinship MJ, Allen JM, Gregorevic P, Chamberlain JS, Metzger JM. Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1086-92. PMID 17440445 DOI: 10.1038/Sj.Mt.6300144  0.618
2007 Wang Z, Kuhr CS, Allen JM, Blankinship M, Gregorevic P, Chamberlain JS, Tapscott SJ, Storb R. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1160-6. PMID 17426713 DOI: 10.1038/Sj.Mt.6300161  0.666
2007 Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, Finn EE, Nguyen QG, Blankinship MJ, Meuse L, Chamberlain JS, Hauschka SD. Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 320-9. PMID 17235310 DOI: 10.1038/Sj.Mt.6300027  0.786
2006 Gregorevic P, Allen JM, Minami E, Blankinship MJ, Haraguchi M, Meuse L, Finn E, Adams ME, Froehner SC, Murry CE, Chamberlain JS. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nature Medicine. 12: 787-9. PMID 16819550 DOI: 10.1038/Nm1439  0.744
2006 Blankinship MJ, Gregorevic P, Chamberlain JS. Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 241-9. PMID 16361117 DOI: 10.1016/J.Ymthe.2005.11.001  0.701
2006 Salva MZ, Himeda CL, Tai P, Nishiuchi E, Finn EE, Allen JM, Gregorevic P, Blankinship MJ, Meuse LA, Chamberlain JS, Hauschka SD. 561. Novel Tissue-Specific Regulatory Cassettes Direct High-Level Transgene Expression in Skeletal and Cardiac Muscle Molecular Therapy. 13: S216. DOI: 10.1016/J.Ymthe.2006.08.634  0.778
2006 Gregorevic P, Blankinship MJ, Minami E, Allen JM, Murry CE, Chamberlain JS. 35. Systemic Administration of rAAV6-Microdystrophin Preserves Muscle Function and Extends Lifespan in the Dystrophin-/Utrophin- Mouse Model of Severe Muscular Dystrophy Molecular Therapy. 13: S15. DOI: 10.1016/J.Ymthe.2006.08.048  0.777
2005 Wang Z, Blankinship MJ, Gregorevic P, Little M, Storb RJ, Allen JM, Tapscott SJ, Chamberlain JS, Kuhr CS. 791. Immunity to AAV-Mediated Gene Therapy in a Random-Bred Canine Model of Duchenne Muscular Dystrophy Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.329  0.519
2005 Salva MZ, Himeda CL, Tai P, Blankinship MJ, Gregorevic P, Allen JM, Meuse LA, Chamberlain JS, Hauschka SD. 266. Development of rAAV-Based Skeletal and Cardiac Muscle Regulatory Cassettes for Gene Therapy of Duchenne Muscular Dystrophy Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.269  0.78
2004 Gregorevic P, Blankinship MJ, Chamberlain JS. Viral vectors for gene transfer to striated muscle. Current Opinion in Molecular Therapeutics. 6: 491-8. PMID 15537050  0.756
2004 Blankinship MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, Miller AD, Miller DA, Chamberlain JS. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 671-8. PMID 15451451 DOI: 10.1016/J.Ymthe.2004.07.016  0.78
2004 Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG, Russell DW, Chamberlain JS. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nature Medicine. 10: 828-34. PMID 15273747 DOI: 10.1038/Nm1085  0.776
2004 Gregorevic P, Blankinship MJ, Allen JM, Meuse L, Han J, Oakley S, Chamberlain JS. 718. Systemic Gene Transfer to Striated Muscles Using rAAV6 Vectors Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.624  0.746
2004 Blankinship MJ, Gregorevic P, Chamberlain JS. 433. Micro-Utrophin as a Therapeutic Protein in rAAV Mediated Gene Therapy for Duchenne Muscular Dystrophy Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.398  0.556
Show low-probability matches.